Results 11 to 20 of about 129,350 (262)
Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction [PDF]
Background: The term “end stage” has been used to describe hypertrophic cardiomyopathy (HCM) with left ventricular systolic dysfunction (LVSD), defined as occurring when left ventricular ejection fraction is <50%. The prognosis of HCM-LVSD has reportedly been poor, but because of its relative rarity, the natural history ...
Marstrand, Peter +16 more
openaire +7 more sources
There is a common assumption that a normal electrocardiography rules out chronic heart failure due to left ventricular systolic dysfunction (LVSD). In this research work, an assessment of the value of electrocardiography in identifying patients with ...
Hanan G. K Altalhi, Asgad A Abdalgbar
doaj +1 more source
Sepsis-related cardiomyopathy: Not an easy task for ICU physicians
Sepsis-induced myocardial dysfunction is common. In addition to acute coronary syndrome, at least two types of left ventricular dysfunction can occur in septic patients: typical septic cardiomyopathy (SC) and sepsis-related takotsubo cardiomyopathy (ST).
Hongmin Zhang, Dawei Liu
doaj +1 more source
Detection of Left Ventricular Systolic Dysfunction From Electrocardiographic Images
BACKGROUND: Left ventricular (LV) systolic dysfunction is associated with a >8-fold increased risk of heart failure and a 2-fold risk of premature death. The use of ECG signals in screening for LV systolic dysfunction is limited by their availability to clinicians.
Veer Sangha +19 more
openaire +4 more sources
Reversible Left Ventricular Systolic Dysfunction Secondary to Pazopanib [PDF]
Pazopanib is a tyrosine kinase inhibitor used for the treatment of advanced renal cell carcinoma and advanced soft tissue sarcoma. We describe a case report of a patient with spindle cell sarcoma who developed severe left ventricular systolic dysfunction after starting pazopanib therapy with subsequent recovery of left ventricular ejection fraction ...
Gajjar, Kushani +2 more
openaire +2 more sources
Atorvastatin in Nonischemic Left Ventricular Systolic Dysfunction
Sola et al. ([1][1]) found that atorvastatin improved left ventricular (LV) ejection fraction and reduced LV end diastolic dimensions in patients with nonischemic heart failure (HF) ([1][1]). Nonischemic HF is a heterogeneous condition with a variable clinical course.
Bahl, Ajay, Chongtham, Dhanaraj Singh
openaire +2 more sources
Evaluation of left ventricular function in diabetics with ischemic heart disease
Background: Diabetes mellitus is a major risk factor for coronary artery disease, with a higher incidence of myocardial infarction and sudden death. Left ventricular dysfunction is difficult to diagnose and to differentiate into diastolic and systolic ...
Affan E. Hassan +3 more
doaj +1 more source
Ross procedure in patients with severe left ventricular systolic dysfunction
The Ross procedure outcomes in patients with left ventricular dysfunction are presented. 20 Ross procedures were performed in patients with aortic disease complicated by severe left ventricular dysfunction.
А. М. Караськов +7 more
doaj +1 more source
Introduction. Left ventricular dysfunction is quite common in septic shock. Speckle-tracking echocardiography (STE) is a novel, highly sensitive method for assessing left ventricular function, capable of detecting subclinical myocardial dysfunction ...
Pham Dang Hai +7 more
doaj +1 more source
Background: The prevalence and clinical outcomes of heart failure with preserved left ventricular ejection fraction after acute myocardial infarction have not been well elucidated. Objective: To analyze the prevalence of heart failure with preserved left
Lucas Antonelli +9 more
doaj +1 more source

